Pages that link to "Q26824024"
Jump to navigation
Jump to search
The following pages link to MicroRNAs as pharmacological targets in diabetes (Q26824024):
Displaying 20 items.
- Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives (Q26765972) (← links)
- The emerging role of epigenetics in cardiovascular disease (Q26852614) (← links)
- The potential of microRNAs in personalized medicine against cancers (Q34177547) (← links)
- MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review (Q34394249) (← links)
- Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells. (Q35925909) (← links)
- MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes (Q36013285) (← links)
- Disease, Models, Variants and Altered Pathways-Journeying RGD Through the Magnifying Glass (Q36427543) (← links)
- Development of Insulin Resistance through Induction of miRNA-135 in C2C12 Cells (Q37232019) (← links)
- MicroRNAs and Cardiovascular Disease in Diabetes Mellitus (Q37680890) (← links)
- IRS-2 Partially Compensates for the Insulin Signal Defects in IRS-1-/- Mice Mediated by miR-33. (Q37683511) (← links)
- miRNAs target databases: developmental methods and target identification techniques with functional annotations (Q38436885) (← links)
- Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease? (Q38481462) (← links)
- MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases (Q39040841) (← links)
- Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia (Q39568148) (← links)
- Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome (Q41014418) (← links)
- microRNA-16 Is Downregulated During Insulin Resistance and Controls Skeletal Muscle Protein Accretion (Q42127502) (← links)
- The MicroRNA-21 signaling pathway is involved in prorenin receptor (PRR) -induced VEGF expression in ARPE-19 cells under a hyperglycemic condition (Q42290908) (← links)
- A dual discrimination mode for improved specificity towards let-7a detection via a single-base mutated padlock probe-based exponential rolling circle amplification. (Q48161842) (← links)
- Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs (Q60305262) (← links)
- miR-216a-targeting theranostic nanoparticles promote proliferation of insulin-secreting cells in type 1 diabetes animal model (Q90633748) (← links)